National Kidney Foundation Partners With NephCure and the International Society of Glomerular Disease to Advance Kidney Disease Research

Collaboration aims to connect more patients and researchers with NKF’s KidneyCARE® Study 

(New York City, NY – November 17, 2026) - The National Kidney Foundation (NKF) today announced a collaboration with NephCure and the International Society of Glomerular Disease (ISGD) to expand the reach of the KidneyCARE® Study, NKF’s national registry for people living with kidney disease. The collaboration will focus on engaging more people with glomerular diseases, which affect the kidneys’ filtering units, and connecting the study with clinicians and researchers who specialize in these conditions. 

The KidneyCARE Study is designed to gather information directly from people living with different types and stages of kidney disease, including how their condition and treatment affect their daily lives. NephCure will help raise awareness of the study among people living with rare glomerular diseases. ISGD will engage its international network of clinicians and researchers to support research on these conditions. 

“People living with kidney disease can tell us how symptoms and treatments affect their lives between clinic visits,” said Kerry Willis, Ph.D., Chief Scientific Officer of the National Kidney Foundation. “Working with NephCure and ISGD will help us hear from more people living with glomerular disease and bring their experiences into research.”  

“This partnership allows us to combine our strengths with NKF and ISGD to accelerate discovery and ensure patient voices remain central to research and patient care,” said Lauren Eva, Chief Operating Officer at NephCure. “Together, we can make progress in identifying patients at risk earlier and improving their outcomes.” 

“By linking the patient registry with our international research community, we can provide researchers with better tools and data to improve treatments and ultimately improve the lives of people living with kidney disease,” said Barbara Gillespie, Chief Medical and Strategy Officer of ISGD. 

To learn more about the study and who can participate, visit kidneycarestudy.org. 

About Kidney Disease  
In the United States, more than 37 million adults are estimated to have kidney disease, also known as chronic kidney disease (CKD)—and approximately 90 percent don’t know they have it. About 1 in 3 adults in the U.S. are at risk for kidney disease. Risk factors for kidney disease include: diabetes, high blood pressure, heart disease, obesity, and family history. People of Black or African American, Hispanic or Latino, American Indian or Alaska Native, Asian American, or Native Hawaiian or Other Pacific Islander descent are at increased risk for developing the disease. Black or African American people are about four times as likely as White people to have kidney failure. Hispanics experience kidney failure at about double the rate of White people. 

About the National Kidney Foundation  
The National Kidney Foundation is revolutionizing the fight to save lives by eliminating preventable kidney disease, accelerating innovation for the dignity of the patient experience, and dismantling structural inequities in kidney care, dialysis, and transplantation. For more information about kidney disease, please visit www.kidney.org. 

About NephCure 
NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible. 

About International Society of Glomerular Diseases  
The International Society of Glomerular Disease is a professional nephrology society founded to build the future of glomerular medicine, which includes supporting the experts who care for patients. ISGD seeks to unite global stakeholders to transform and drive advances in glomerular health. For more information, visit www.is-gd.org. 

 

For Media Inquiries: 

Jade Rivera-McFarlin 
413-537-1155 
jade.riveramcfarlin@kidney.org  

###